Bariatric surgery is the most effective available treatment for obesity. The most frequently
performed operation, Roux-en-Y gastric bypass (RYGB), causes profound weight loss and …

The rate of obesity is rising logarithmically, especially in those with severe obesity (body
mass index [BMI] 40 kg/m2). Cardiologists, endocrinologists, internists, family practitioners …

Objectives To determine the efficacies of 2 weight-reducing operations on diabetic control
and the role of duodenum exclusion. Design Double-blind randomized controlled trial …

Background & aims Bile diversion to the ileum (GB-IL) has strikingly similar metabolic and
satiating effects to Roux-en-Y gastric bypass (RYGB) in rodent obesity models. The …

OBJECTIVE Roux-en-Y gastric bypass (RYGB) ameliorates type 2 diabetes in severely
obese patients through mechanisms beyond just weight loss, and it may benefit less obese …

Several gastrointestinal (GI) operations that were designed to promote weight loss can
powerfully ameliorate type 2 diabetes mellitus (T2DM). Although T2DM is traditionally …

Importance Bariatric surgery is beneficial in persons with a body mass index (BMI) of 35 or
greater with obesity-related comorbidities. There is interest in using these procedures in …

Objectives: To develop guidelines for the use of gastrointestinal surgery to treat type 2
diabetes and to craft an agenda for further research. Background: Increasing evidence …

Type 2 diabetes, which accounts for 90–95% of all cases of diabetes, is a growing epidemic
that places a severe burden on health care systems, especially in developing countries …

Gastrointestinal bypass surgeries restore metabolic homeostasis in patients with type 2
diabetes and obesity, but the underlying mechanisms remain elusive. Duodenal-jejunal …